Barinthus Biotherapeutics plc (ADR)
General ticker "BRNS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $43.2M (TTM average)
Barinthus Biotherapeutics plc (ADR) follows the US Stock Market performance with the rate: 21.1%.
Estimated limits based on current volatility of 3.1%: low 0.71$, high 0.75$
Factors to consider:
- Total employees count: 130 as of 2023
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.71$, 1.80$]
- 2025-12-31 to 2026-12-31 estimated range: [0.69$, 1.72$]
Financial Metrics affecting the BRNS estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -67.07 <= 0.33
- Positive: -4.48 < Investing cash flow per share per price, % of -2.07
- Positive: Interest expense per share per price, % of 0.12 <= 0.79
- Positive: Inventory ratio change, % of -10.40 <= -0.75
Short-term BRNS quotes
Long-term BRNS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $44.70MM | $0.80MM | $14.97MM |
| Operating Expenses | $48.74MM | $84.72MM | $82.94MM |
| Operating Income | $-4.04MM | $-83.91MM | $-67.97MM |
| Non-Operating Income | $4.89MM | $7.39MM | $6.74MM |
| Interest Expense | $0.02MM | $0.03MM | $0.05MM |
| R&D Expense | $41.11MM | $41.41MM | $38.25MM |
| Income(Loss) | $0.85MM | $-76.52MM | $-61.23MM |
| Taxes | $-4.47MM | $-3.08MM | $-0.04MM |
| Profit(Loss)* | $5.34MM | $-73.35MM | $-61.07MM |
| Stockholders Equity | $242.90MM | $186.78MM | $130.03MM |
| Assets | $270.20MM | $214.51MM | $160.33MM |
| Operating Cash Flow | $-14.43MM | $-50.92MM | $-28.94MM |
| Capital expenditure | $6.14MM | $5.41MM | $0.89MM |
| Investing Cash Flow | $-5.75MM | $-5.41MM | $-0.89MM |
| Financing Cash Flow | $0.33MM | $1.87MM | $2.16MM |
| Earnings Per Share** | $0.14 | $-1.91 | $-1.55 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.